CD22 (CD22 Molecule) also known as SIGLEC2, it is a Protein Coding gene. Sialic acid-binding immunoglobulin-like lectin (Siglec) receptors are a family of 14 cell surface transmembrane proteins that bind specifically to sialic acid (Sia)-containing glycans, facilitating cell adhesion and/or cell signaling1. CD22 (Siglec 2) is a receptor predominantly restricted to B cells, it is a single-spanning membrane glycoprotein of 140 kDa on the surface of B cells. The cis/trans binding modes of CD22, together with a multi-Ig domain topology imply that the biological function of CD22 might be facilitated by significant conformational plasticity. Diseases associated with CD22 include Hematologic Cancer and Refractory Hairy Cell Leukemia.